HIV scientists launch EUR23 million project to develop vaccine
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today.
Nov 2, 2015
0
18
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today.
Nov 2, 2015
0
18
European Union regulators have given Swiss pharmaceutical group Novartis a green light to market its drug Signifor as a treatment for Cushing's disease, the company said Wednesday.
Apr 25, 2012
0
0
The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
The European Commission intends to terminate an agreement to buy the COVID vaccine of French-Austria drug maker Valneva as the shot has yet to receive marketing authorisation, the company said Monday.
May 16, 2022
0
6
Franco-Austrian biotech firm Valneva will supply the European Union with as many as 60 million doses of its COVID-19 vaccine under the terms of a deal announced on Wednesday.
Nov 10, 2021
0
23
The European Commission on Tuesday put forward a proposal that would let patients access their medical data anywhere in the bloc, creating an EU-wide platform that could also be used for research.
May 3, 2022
0
1
The European Commission said Thursday it had approved French pharmaceutical giant Sanofi's acquisition of German peer Boehringer Ingelheim's consumer health business, subject to conditions.
Aug 4, 2016
0
1
The CEO of US biotech company Moderna warned European countries Tuesday that dragging out negotiations to buy its promising COVID-19 vaccine will slow down deliveries, as other nations that have signed deals will get priority.
Nov 17, 2020
0
1
Parents say health claims on food are 'baffling' and use own knowledge of food to guide healthy purchases as industry leaders and consumers meet to discuss the need for a change in food labeling, specifically health claims.
Jan 3, 2020
0
2
The EU on Wednesday tightened its rules on Covid-19 vaccine exports, making authorisations contingent on destination countries behaving fairly in return—particularly vaccine-producing ones.
Mar 24, 2021
0
2